Company intelligence / Profile preview

Cathay Fortune

Shanghai, Shanghai, China
Ownership
Private
Development stage
Other
01

Overview

Cathay Fortune Corp, also known as Hongshang Group, is a prominent private investment conglomerate based in Shanghai with a strategic focus on life sciences, natural resources, and financial services. The company is a major player in the biotechnology sector primarily through its significant equity stakes in GenScript Biotech and its subsidiary Legend Biotech, which developed the landmark CAR-T therapy Carvykti. Through these holdings, Cathay Fortune is integrated into the synthetic biology, cell therapy, and life science research service markets. Additionally, the group maintains a presence in healthcare delivery and medical device manufacturing via its interests in Chimin Health Management. For a life sciences analyst, Cathay Fortune represents a major source of institutional capital and strategic control within the global biotech and pharmaceutical manufacturing ecosystems.

Therapeutic areas
OncologyImmunology
Modalities
CAR-T cell therapyCell therapyGene therapyMonoclonal antibodySmall molecule
Industry
Investors
02

Partnerships

Johnson & Johnson/Janssen (via Legend Biotech)Novartis (via GenScript)

Beyond the preview

Go deeper on Cathay Fortune.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cathay Fortune.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call